Follow
Sara Nidal Abed
Title
Cited by
Cited by
Year
Computer-aided prediction of pharmacokinetic (ADMET) properties
B Chandrasekaran, SN Abed, O Al-Attraqchi, K Kuche, RK Tekade
Dosage form design parameters, 731-755, 2018
1542018
Pharmaceutical and biomedical applications of polymers
PK Deb, SF Kokaz, SN Abed, A Paradkar, RK Tekade
Basic fundamentals of drug delivery, 203-267, 2019
662019
Medicinal chemistry and therapeutic potential of agonists, antagonists and allosteric modulators of A1 adenosine receptor: current status and perspectives
PK Deb, S Deka, P Borah, SN Abed, KN Klotz
Current Pharmaceutical Design 25 (25), 2697-2715, 2019
452019
Reinforced electrospun nanofiber composites for drug delivery applications
N Anup, T Chavan, S Chavan, S Polaka, D Kalyane, SN Abed, ...
Journal of Biomedical Materials Research Part A 109 (10), 2036-2064, 2021
262021
Influence of drug properties and routes of drug administration on the design of controlled release system
A Indurkhya, M Patel, P Sharma, SN Abed, A Shnoudeh, R Maheshwari, ...
Dosage form design considerations, 179-223, 2018
192018
Larvicidal Activities of 2-Aryl-2,3-Dihydroquinazolin -4-ones against Malaria Vector Anopheles arabiensis, In Silico ADMET Prediction and Molecular Target …
KN Venugopala, P Ramachandra, C Tratrat, RM Gleiser, S Bhandary, ...
Molecules 25 (6), 1316, 2020
182020
Nanocarriers in Different Preclinical and Clinical Stages
SN Abed, PK Deb, HS Surchi, SF Kokaz, SM Jamal, S Bandopadhyay, ...
Basic Fundamentals of Drug Delivery, 685-731, 2019
172019
Aerosols in pharmaceutical product development
PK Deb, SN Abed, H Maher, A Al-Aboudi, A Paradkar, S Bandopadhyay, ...
Drug Delivery Systems, 521-577, 2020
122020
Strategies for pulmonary delivery of drugs
R Deshmukh, N Bandyopadhyay, SN Abed, S Bandopadhyay, Y Pal, ...
Drug Delivery Systems, 85-129, 2020
112020
Four stages of pharmaceutical product development: preformulation, prototype development and scale-up, biological aspects, and commercialization
B Amarji, SN Abed, U Bairagi, PK Deb, O Al-Attraqchi, AA Choudhury, ...
Dosage Form Design Considerations, 637-668, 2018
102018
Particulate level properties and its implications on product performance and processing
PK Deb, SN Abed, AMY Jaber, RK Tekade
Dosage Form Design Parameters, 155-220, 2018
92018
Dissolution profile consideration in pharmaceutical product development
D Mehtani, A Seth, P Sharma, R Maheshwari, SN Abed, PK Deb, ...
Dosage form design considerations, 287-336, 2018
92018
Pharmacology of GABA and its receptors
S Kaur, S Singh, A Arora, P Ram, S Kumar, P Kumar, SN Abed
Frontiers in pharmacology of neurotransmitters, 241-292, 2020
62020
Dissolution Profile Consideration in Pharmaceutical Product Development. Dosage Form Design Considerations: Volume I
D Mehtani, A Seth, P Sharma, R Maheshwari, SN Abed, PK Deb
Elsevier Inc, 2018
62018
Pharmacology of acetylcholine and cholinergic receptors
SF Kokaz, PK Deb, SN Abed, A Al-Aboudi, N Das, FA Younes, RA Salou, ...
Frontiers in Pharmacology of Neurotransmitters, 69-105, 2020
42020
Neurotransmitters and Their Receptors—State of the Art
P Kumar, SN Abed, YA Bataineh, MS Salem
Frontiers in Pharmacology of Neurotransmitters, 1-29, 2020
22020
Herbal medication and nutraceuticals for the management of anxiety and depression
SN Abed, FA Younes, HS Surchi, PK Deb
Current Psychopharmacology 7 (2), 129-148, 2018
22018
Ethics and Legal Protection of Uses of Computer Applications in Pharmaceutical Research
B Chandrasekaran, DER Osman, SN Abed, RK Tekade, M Tekade
Dosage Form Design Parameters, 757-770, 2018
22018
Pharmacology of Adenosine Receptors
PK Deb, SF Kokaz, SN Abed, B Chandrasekaran, W Hourani, AY Jaber, ...
Frontiers in Pharmacology of Neurotransmitters, 325-359, 2020
12020
The system can't perform the operation now. Try again later.
Articles 1–19